Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLatest revision on 2026-02-05 (v3.4.2) adds Returned date, Quality Control Review Has Not Concluded, and new study sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. It also removes the older government funding notice and the prior revision (v3.4.1).SummaryDifference2%

- Check21 days agoChange DetectedA government funding notice banner was added and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe additions describe UI and versioning details on the history page (Show glossary, Results Submitted, color-coded highlights for additions and deletions, and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the history and an older entry v3.3.3 was removed. This update affects only the history log metadata and does not alter study data or page functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedMinor UI updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2', with no impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedNew entries for Contacts/Locations and Study Status were added in the record history (dated 2025-12-04 and 2025-12-03). A deletion was recorded on 2025-10-09.SummaryDifference0.4%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.